Literature DB >> 25483831

Statin use increases the risk of depressive disorder in stroke patients: a population-based study.

Jiunn-Horng Kang1, Li-Ting Kao2, Herng-Ching Lin3, Ming-Chieh Tsai4, Shiu-Dong Chung5.   

Abstract

This study aimed to explore the risk for depressive disorder (DD) among stroke patients with statin use. Totally, 11,218 patients who had a first-time acute hospitalization for stroke were identified from Taiwan's Longitudinal Health Insurance Database 2000. We individually followed each study subject for a 1-year period to identify those patients who were subsequently diagnosed with DD during the follow-up period. We found that the incidence rate of DD during the 1-year follow-up period was 5.52 (95% CI: 4.70-6.43) and 3.46 (95% CI: 3.08-3.88) per 100 person-years for stroke patients who were statin users and nonusers, respectively. Cox proportional hazards regressions revealed that the adjusted hazard ratio (HR) for DD during the 1-year follow-up period was 1.59 for stroke patients who were statin users compared to those who were non-statin users. We further found that the adjusted HR for DD for stroke patients who were regular statin users was 1.65 compared to stroke patients who had never been prescribed statin. However, there was no increased hazard of DD for stroke patients who were irregular statin users compared to stroke patients who had never been prescribed statin (HR: 1.22, 95% CI: 0.70-2.11).
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Cerebrovascular disease; Depression; Depressive disorder; Epidemiology; Statin; Stroke

Mesh:

Substances:

Year:  2014        PMID: 25483831     DOI: 10.1016/j.jns.2014.11.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Anti-inflammatory treatment and risk for depression after first-time stroke in a cohort of 147 487 Danish patients.

Authors:  Ida Kim Wium-Andersen; Marie Kim Wium-Andersen; Martin Balslev Jørgensen; Merete Osler
Journal:  J Psychiatry Neurosci       Date:  2017-09       Impact factor: 6.186

Review 2.  Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.

Authors:  Michael Maes; Gabriel Nowak; Javier R Caso; Juan Carlos Leza; Cai Song; Marta Kubera; Hans Klein; Piotr Galecki; Cristiano Noto; Enrico Glaab; Rudi Balling; Michael Berk
Journal:  Mol Neurobiol       Date:  2015-05-02       Impact factor: 5.590

3.  Chronic Neuroinflammation Induced by Lipopolysaccharide Injection into the Third Ventricle Induces Behavioral Changes.

Authors:  Shufang Na; Xuejiao Duan; Rongyan Wang; Yanjie Fan; Ke Xue; Shuwei Tian; Zheqiong Yang; Ke Li; Jiang Yue
Journal:  J Mol Neurosci       Date:  2021-01-06       Impact factor: 3.444

Review 4.  Inflammation, Autoimmunity, Infection, and Stroke: Epidemiology and Lessons From Therapeutic Intervention.

Authors:  Neal S Parikh; Alexander E Merkler; Costantino Iadecola
Journal:  Stroke       Date:  2020-02-12       Impact factor: 7.914

5.  Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.

Authors:  Maciej Banach; Manfredi Rizzo; Peter P Toth; Michel Farnier; Michael H Davidson; Khalid Al-Rasadi; Wilbert S Aronow; Vasilis Athyros; Dragan M Djuric; Marat V Ezhov; Robert S Greenfield; G Kees Hovingh; Karam Kostner; Corina Serban; Daniel Lighezan; Zlatko Fras; Patrick M Moriarty; Paul Muntner; Assen Goudev; Richard Ceska; Stephen J Nicholls; Marlena Broncel; Dragana Nikolic; Daniel Pella; Raman Puri; Jacek Rysz; Nathan D Wong; Laszlo Bajnok; Steven R Jones; Kausik K Ray; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

6.  Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis.

Authors:  K L Ong; M J Morris; R L McClelland; J Maniam; M A Allison; K-A Rye
Journal:  Transl Psychiatry       Date:  2016-11-29       Impact factor: 6.222

7.  Do outpatient statins and ACEIs/ARBs have synergistic effects in reducing the risk of pneumonia? A population-based case-control study.

Authors:  Jiunn-Horng Kang; Li-Ting Kao; Herng-Ching Lin; Ta-Jung Wang; Tsung-Yeh Yang
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

8.  Protocol for analyses of adverse event data from randomized controlled trials of statin therapy.

Authors: 
Journal:  Am Heart J       Date:  2016-01-28       Impact factor: 4.749

9.  Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies.

Authors:  Riccardo De Giorgi; Nicola Rizzo Pesci; Alice Quinton; Franco De Crescenzo; Philip J Cowen; Catherine J Harmer
Journal:  Front Psychiatry       Date:  2021-07-27       Impact factor: 4.157

10.  Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review.

Authors:  Fanny Villoz; Christina Lyko; Cinzia Del Giovane; Nicolas Rodondi; Manuel R Blum
Journal:  BMJ Open       Date:  2021-08-03       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.